|
|
BioNxt Solutions Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization39.47 mln
Float128 mln
Earnings Date06/03/2025
Relative Strength
44
/ 100
Slightly lagging
Pre-Tax Margin
-62,141%
Severely loss-making
Key Fundamentals
EPS-0.07
ROE117
ROIC-114
ROA-752
Interest Cover-4.70
EBITDA, mln-5.86
EV / EBITDA-8.37
EV / EBIT-8.36
Revenue, mln0.01
EV / Revenue4,453
Quote Details
Last
0.26
Change
-0.025 (-8.77%)
Open
0.255
Volume
10,000
Turnover
2,600
Average Volume
30,461
Financial Ratios
Pre-Tax Profit Margin-62,141
Current Ratio0.19
Financial Strength
Altman Z-Score-84.24
Piotroski F-Score
4
/ 9
Beneish M-Score6518
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-10.34% |
32
/ 100
 |
| 1 Month |
-22.39% |
47
/ 100
 |
| 2 Months |
-21.21% |
53
/ 100
 |
| 6 Months |
-50.94% |
35
/ 100
 |
| 1 Year |
-70.79% |
18
/ 100
 |
|
| |
